Healthcare Realty Trust announces Todd Meredith as upcoming CEO alongside David Emery as Executive Chairman

– USA, TN – Healthcare Realty Trust Incorporated (NYSE: HR) today announced that Todd J. Meredith has been appointed as the Company’s President and Chief Executive Officer effective December 30, 2016. The Company expects that Mr. Meredith will also be nominated to serve on the board of directors in 2017. The Company’s current CEO, David R. Emery, will transition into the role of Executive Chairman beginning December 30, 2016 for a term of five years. Mr. Emery is the founder of the Company and has served as its CEO and Chairman of the Board since its inception in 1992.

Mr. Meredith (age 41) has been employed by the Company since 2001. He was appointed Executive Vice President – Investments in February 2011 and is responsible for overseeing the Company’s investment activities, including the acquisition, financing and development of medical office and other outpatient medical facilities. Prior to February 2011, he led the Company’s development activities as a Senior Vice President. Before joining the Company in 2001, Mr. Meredith worked in investment banking.

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. The Company had investments of approximately $3.3 billion in 198 real estate properties as of December 31, 2015. The Company’s 198 owned real estate properties are located in 30 states and total approximately 14.3 million square feet. The Company provided leasing and property management services to approximately 9.8 million square feet nationwide.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>